Global Biopreservation Industry

Jan 11, 2016, 16:52 ET from Reportlinker

NEW YORK, Jan. 11, 2016 /PRNewswire/ -- This report analyzes the worldwide markets for Biopreservation in US$ Million. The Global market is further analyzed by the following Product Segments, Applications, and Biospecimen Type - Product Segments: Equipment, and Media; Applications: R&D, Therapeutic, and Others; Biospecimen Types: Organs, Stem Cells, Tissues, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 82 companies including many key and niche players such as -

Atlanta Biologicals, Inc.
Biocision LLC
Biogenics Inc.
Biolife Solutions, Inc.
Cell & Tissue Systems, Inc.



Read the full report: http://www.reportlinker.com/p03549684-summary/view-report.html



I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definition and Scope of Study I-3

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW.............. II-1 Biopreservation - A Critical Activity for Improving Human Healthcare.............. II-1 Rapidly Mushrooming Biorepositories Portend Bright Outlook for Market Growth.............. II-2 Western Countries Dominate, Developing Economies to Lend Growth Momentum.............. II-3 R&D and Therapeutic Applications Corner Bulk of Demand II-3 Competitive Scenario..............II-4 Biopreservation Market Remains Highly Competitive II-4 Table 1: Global Biopreservation Equipment Market by Leading Players (2014): Percentage Market Share Breakdown of Dollar Revenues for Biogenics, BioCision, Cesca Therapeutics, Custom Biogenic Systems, Princeton Cryotech, So-Low Environmental Equipment, Taylor-Wharton Cryogenics, Thermo Fisher Scientific, VWR International, and Others (includes corresponding Graph/Chart)..............II-4 Custodiol HTK Gains Prominence vs. the Gold Standard UW Solution.............. II-5

2. MAJOR GROWTH DRIVERS & MARKET TRENDS II-6 Improving Healthcare Expenditure Propels Demand II-6 Table 2: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart) II-6

Table 3: Healthcare Spending as a Percentage of GDP in Select Countries (2013) (includes corresponding Graph/Chart) II-7 Development of Regenerative Medicine Accelerates Demand for Improved Biopreservation Solutions II-7 Table 4: Global Regenerative Medicines Market by Category (2015E): Percentage Breakdown for Biopharmaceuticals, Cell and Tissue-Based Therapies, and Regenerative Devices & Compounds (includes corresponding Graph/Chart) II-8 Growing Prevalence of Chronic Diseases Highlights Importance of Maintaining Demographic and Age based Databases II-8 Key Disease Statistics - Opportunity Indicators II-9 Table 5: Worldwide Incidence of Cancer (2012, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart).............. II-9

Table 6: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart).............. II-10

Table 7: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart).............. II-10

Table 8: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart) II-11

Table 9: Global Cost of Respiratory Therapy by Disease (2015): Percentage Breakdown of Therapy Costs for Asthma, Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis, and Others (includes corresponding Graph/Chart).............. II-11 Biopreservation Media Play Pivotal role in Biomarker Exploration and Development of Companion Diagnostics II-12 Advancements in Personalized Medicine - A Megatrend Catalyzing Growth.............. II-12 Growing Awareness of Stem Cell Therapy Propels Market Forward, Stem Cell Research in Top Gear..............II-13 Table 10: Global Stem Cell Usage in Research (2013): Percentage Share Breakdown by Type (includes corresponding Graph/Chart).............. II-14 Advancements in Organ and Tissue Banking Critical for Meeting Huge Unmet Demand for Transplantations II-15 Continuous Hypothermic Perfusion/Hypothermic Perfusion Preservation.............. II-16 New Paradigms in Heart and Lung Preservation II-16 Several Challenges Remain to be Addressed for Cryopreservation of Complex Tissues II-17 Major Strides Achieved in HBS Sample Tracking Technologies II-18 LIMS Suites Integrated with Sample Tracking Modules II-18 RFID Tags - Ideal for Cryogenic Applications II-18 MEMS-Based Tracking Tags Take Biosample Tagging to the Next Level.............. II-19 Need for Harmonization and Networking of Biobanks, Supplemented by Biolibraries and Virtual Biobanks II-19 Commercial Biobanks Slowly Gain Acceptance II-20 Growing Diversity of HBS Increases Spatial Constraints of Biorepositories.............. II-20 Dearth of Standardized and Quality Biospecimens Pose Problems II-21 Mounting Costs and Funding Cutbacks Undermine Viability of Biopreservation.............. II-21 Dried Blood Spots at Room Temperature - A Potential Alternative for Cryogenic Preservation II-23 Donor Engagement and Support - Key to Resolving Ethical and Regulatory Hurdles for Biorepositories II-24 Biorepositories Increasingly Adopt Automation to Boost Productivity.............. II-25 Dry Storage Vessels to Unseat Ultra-low Freezers II-26 Cold Chain Systems - An Overlooked, Albeit Important Aspect of Biopreservation.............. II-27

3. PRODUCT OVERVIEW.............. II-28 Biopreservation.............. II-28 Biopreservation Equipment..............II-28 Biopreservation Media..............II-28 Types of Biopreserved Biospecimens II-29 Applications of Biopreservation Equipment and Media II-29 Therapeutic Applications..............II-29 Research Applications..............II-30 Other Applications.............. II-30

4. PRODUCT INTRODUCTIONS..............II-31 BioLife Solutions Introduces BloodStor 27 NaCl Cryopreservation Media..............II-31 BioCision Submits MAF for ThawSTAR Automated Cell Thawing System to USFDA.............. II-31 BioCision Releases CryoPod Carrier II-31 BioLife Solutions Unveils New Packages for BloodStor and CryoStor Cryopreservation Media II-31 BioCision Launches ThawSTAR™ Automated Sample Thawing System II-31 BioCision LLC Introduces BioT Temperature Stability Systems II-31 Panasonic Debuts New Biomedical Freezer Line for -30°C Storage II-31

5. RECENT INDUSTRY ACTIVITY..............II-32 Asterand Bioscience Takes Over AdeptBio II-32 Roche Acquires Signature Diagnostics II-32 Cyprus, The University of Cyprus to Purchase Biobank II-32 Monash University Commences Biorepository in Alfred Medical Research & Education Precinct II-32 LabConnect Shifts Operations Center to New Facility II-32 Cardio3 BioSciences Adopts BioLife CryoStor Cryopreservation Media for CHART Clinical Trials II-32 Cord Blood Registry Selects BioLife's CryoStor Media for Umbilical Cord Stem Cell Storage II-32 Mayo Clinic Selects BioLife CryoStor Cell Freeze Media for Pediatric CHD Study..............II-33 BioCision to Collaborate with Celgene Cellular Therapeutics for Developing ThawSTAR..............II-33 TxCell Selects BioCision's Temperature Standardization Products for Ovasave Phase IIb Clinical Trial II-33 Brooks Automation Invests into, Collaborates with BioCision II-33 Adaptimmune Adopts BioLife Solutions' CryoStor Cell Freeze Media for Phase I/II, Cell-Based Cancer Therapy II-33 BioLife Solutions, SAVSU Technologies Forms Joint Venture Company, biologistex CCM..............II-33 Parcell Laboratories Selects BioLife Solutions' CryoStor Media for ELA Stem Cell Studies..............II-34 RoosterBio Selects BioLife Solutions' CryoStor Cryopreservation Media for Commercializing hMSC Products II-34 Cesca Therapeutics Secures Contract from Upstate Cord Blood Bank II-34 SeraCare Life Sciences Divests Biorepository Business to Precision Health Holdings..............II-34 Mayo Clinic Establishes Biobank in Arizona for Population-wide Study.............. II-34 Department of Veterans Affairs Commences Gulf War Veterans' Illnesses Biorepository..............II-34 Apollo JV with Saarum Innovations Sets Up First-ever Commercial Biobank in India..............II-34 AstraZeneca Establishes Biobank and Clinical Research Center in Russia.............. II-35 BioCision Announces Collaboration with ATCC II-35 China National Genebank Partners with BioStorage Technologies II-35 DaVita Labs and Myriad RBM Collaborate for Renal Disease Studies II-35 Laboratory Corporation of America Secures CAP Accreditation for LabCorp Biorepository..............II-35 AMSBIO Expands Biorepository and Collection Services II-35 Cell Therapy Catapult, Roslin Cells to Set Up Pluripotent Stem Cells Biobank.............. II-35

6. FOCUS ON SELECT PLAYERS..............II-36 Atlanta Biologicals, Inc. (USA)..............II-36 Biocision LLC (USA).............. II-36 Biogenics Inc. (USA)..............II-37 Biolife Solutions, Inc. (USA)..............II-37 Cell & Tissue Systems, Inc. (USA) II-38 Cesca Therapeutics Inc. (USA)..............II-38 Core Dynamics, Ltd. (Israel)..............II-39 Custom Biogenic Systems, Inc. (USA) II-39 Essential Pharmaceuticals LLC (USA) II-39 Lifeline Scientific, Inc. (USA)..............II-40 Panasonic Biomedical Sales Europe B.V. (The Netherlands) II-40 Preservation Solution, Inc. (USA) II-41 Princeton Cryotech, Inc. (USA) II-42 Sigma-Aldrich Corporation (USA)..............II-42 So-Low Environmental Equipment Co., Inc. (USA) II-43 Taylor-Wharton Cryogenics LLC (USA) II-43 Thermo Fisher Scientific, Inc. (USA) II-44 VWR International LLC (USA)..............II-45 Wak-Chemie Medical Gmbh (Germany) II-45

7. GLOBAL MARKET PERSPECTIVE..............II-46 Table 11: World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............II-46

Table 12: World 8-Year Perspective for Biopreservation Equipment and Media by Geographic Region - Percentage Share Breakdown of Dollar Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart) II-47

Table 13: World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Product Segment - Equipment and Media Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) II-48

Table 14: World 8-Year Perspective for Biopreservation Equipment and Media by Product Segment - Percentage Share Breakdown of Dollar Revenues for Equipment and Media Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart).............. II-49

Table 15: World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Application - R&D, Therapeutic, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) II-50

Table 16: World 8-Year Perspective for Biopreservation Equipment and Media by Application - Percentage Share Breakdown of Dollar Revenues for R&D, Therapeutic, and Others Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart).............. II-51

Table 17: World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Biospecimen Type - Organs, Stem Cells, Tissues, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) II-52

Table 18: World 8-Year Perspective for Biopreservation Equipment and Media by Biospecimen Type - Percentage Share Breakdown of Dollar Revenues for Organs, Stem Cells, Tissues, and Others Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart)..............II-53

III. MARKET

1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 United States: The Single Largest Market for Biopreservation III-1 Innovative Biopreservation Approaches Critical for Transplantation Research..............III-1 Table 19: Waiting List of Patients for Organ Transplants by Organ Type: As of August 2014 (includes corresponding Graph/Chart).............. III-1

Table 20: The US Kidney Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart).............. III-2 Robust Demand for Regenerative Medicines Augurs Well for Biopreservation solutions Market III-3 Aging Population, Rising Incidence of Chronic Diseases Fuel Demand for Biobanking..............III-4 Table 21: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart) III-4

Table 22: CVD in the US: Cardiovascular Disease Prevalence in Adults by Gender & Age Group (includes corresponding Graph/Chart).............. III-5

Table 23: New Cancer Cases in Males in US by Body Site (2014) (includes corresponding Graph/Chart) III-5

Table 24: New Cancer Cases in Females in US by Body Site (2014) (includes corresponding Graph/Chart) III-6 Product Introductions..............III-6 Strategic Corporate Developments III-7 Select Key Players..............III-10 B.Market Analytics..............III-19 Table 25: The US Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-19

2. CANADA.............. III-20 A.Market Analysis.............. III-20 Current and Future Analysis..............III-20 Canada Emerges as a Significant Player in the Field of Regenerative Medicine..............III-20 Canadians More Receptive to Organ Transplants III-20 Table 26: Canadian Patients on Active Waiting List for Organ Transplants by Type: 2012 (includes corresponding Graph/Chart).............. III-21 B.Market Analytics..............III-21 Table 27: Canadian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-21

3. JAPAN.............. III-22 A.Market Analysis.............. III-22 Current and Future Analysis..............III-22 Urgent Need for Regenerative Therapeutics in Geriatric Healthcare and Cancer Care to Drive Demand for Biopreservation Media..............III-22 Table 28: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart) III-23

Table 29: Cancer Related Deaths by Age Group in Japan (2013) (includes corresponding Graph/Chart) III-23 B.Market Analytics..............III-24 Table 30: Japanese Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-24

4. EUROPE.............. III-25 A.Market Analysis.............. III-25 Current and Future Analysis..............III-25 Ageing Population to Drive Demand for Regenerative Medicines III-25 Table 31: European Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart) III-26

Table 32: European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart)..............III-27 Increasing Organ Transplantations Drive the Need for Preservation.............. III-28 Table 33: European Deceased Organ Donation Rates Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart) III-28

Table 34: European Living Organ Donation Rates Per Million Population (PMP) by Country for 2013 (includes corresponding Graph/Chart)..............III-28

Table 35: European Single Organ Transplantations by Select Country and Organ Type: 2013..............III-29

Table 36: European Multi-Organ Transplantations by Select Country and Transplant Type: 2013 III-29 Cancer in Europe: Key Statistics III-29 Table 37: Number of New Cancer Cases in Europe: 2012-2030 (includes corresponding Graph/Chart) III-29 B.Market Analytics..............III-30 Table 38: European Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Geographic Region - France, Germany, Italy, UK, Spain, Russia, The Netherlands, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) III-30

Table 39: European 8-Year Perspective for Biopreservation Equipment and Media by Geographic Region - Percentage Share Breakdown of Dollar Revenues for France, Germany, Italy, UK, Spain, Russia, The Netherlands, and Rest of Europe Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart).............. III-31

4a. FRANCE.............. III-32 Market Analysis.............. III-32 Table 40: French Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-32

4b. GERMANY.............. III-33 A.Market Analysis.............. III-33 Current and Future Analysis..............III-33 Germany Holds Strong Position in European Regenerative Medicine Sector..............III-33 Strategic Corporate Development III-33 Wak-Chemie Medical Gmbh - A Key German Player III-33 B.Market Analytics..............III-34 Table 41: German Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-34

4c. ITALY.............. III-35 A.Market Analysis.............. III-35 Current and Future Analysis..............III-35 B.Market Analytics..............III-35 Table 42: Italian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-35

4d. THE UNITED KINGDOM..............III-36 A.Market Analysis.............. III-36 Current and Future Analysis..............III-36 NHS Initiatives for Promulgating Organ Translation Ramp up Usage of Organ Preservation Solutions III-36 Table 43: The UK Organ Donors by Type: May 2015 & May 2014 (includes corresponding Graph/Chart) III-36

Table 44: The UK Organ Transplantation by Type: 2014 Vs. 2015 (includes corresponding Graph/Chart) III-37 Strategic Corporate Development III-37 B.Market Analytics..............III-38 Table 45: UK Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-38

4e. SPAIN.............. III-39 A.Market Analysis.............. III-39 Current and Future Analysis..............III-39 B.Market Analytics..............III-39 Table 46: Spanish Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-39

4f. RUSSIA.............. III-40 A.Market Analysis.............. III-40 Current and Future Analysis..............III-40 Strategic Corporate Development III-40 B.Market Analytics..............III-41 Table 47: Russian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-41

4g. THE NETHERLANDS.............. III-42 A.Market Analysis.............. III-42 Current and Future Analysis..............III-42 Panasonic Biomedical Sales Europe B.V. - A Key Dutch Player III-42 B.Market Analytics..............III-43 Table 48: The Netherlands Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) III-43

4h. REST OF EUROPE.............. III-44 A.Market Analysis.............. III-44 Current and Future Analysis..............III-44 B.Market Analytics..............III-44 Table 49: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) III-44

5. ASIA-PACIFIC.............. III-45 A.Market Analysis.............. III-45 Current and Future Analysis..............III-45 India & China Offer Significant Growth Opportunities III-45 Table 50: Population Statistics in Select Asian Countries & Percentage of Population Aged Above 65 Years (includes corresponding Graph/Chart)..............III-46 Organ Transplantation Statistics III-47 Table 51: Asia-Pacific Deceased Organ Donor Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)..............III-47

Table 52: Asia-Pacific Living Organ Donor Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)..............III-47 B.Market Analytics..............III-48 Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-48

Table 54: Asia-Pacific 8-Year Perspective for Biopreservation Equipment and Media by Geographic Region - Percentage Share Breakdown of Dollar Revenues for China, India, and Rest of Asia-Pacific Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart) III-49

5a. CHINA.............. III-50 A.Market Analysis.............. III-50 Current and Future Analysis..............III-50 Government Support to Bolster Growth of Regenerative Medicines Market.............. III-50 Organ Transplantations in China: Years 2010 to 2013 in Review III-50 Transplantation Tourism in China III-50 Strategic Corporate Development III-51 B.Market Analytics..............III-51 Table 55: Chinese Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-51

5b. INDIA.............. III-52 A.Market Analysis.............. III-52 Current and Future Analysis..............III-52 Stem Cell Therapy Market Poised for Robust Growth III-52 Low Organ Transplantation Expenses Boost Medical Tourism III-53 Strategic Corporate Development III-53 B.Market Analytics..............III-54 Table 56: Indian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-54

5c. REST OF ASIA-PACIFIC..............III-55 A.Market Analysis.............. III-55 Current and Future Analysis..............III-55 Australia.............. III-55 Table 57: Australia Organ Transplantations by Organ Type: 2015 (includes corresponding Graph/Chart) III-55

Table 58: Australian Organ Transplants by State: 2015 (includes corresponding Graph/Chart) III-56 Strategic Corporate Development III-56 B.Market Analytics..............III-57 Table 59: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) III-57

6. LATIN AMERICA.............. III-58 A.Market Analysis.............. III-58 Current and Future Analysis..............III-58 B.Market Analytics..............III-58 Table 60: Latin America Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-58

Table 61: Latin America 8-Year Perspective for Biopreservation Equipment and Media by Geographic Region - Percentage Share Breakdown of Dollar Revenues for Brazil, and Rest of Latin America Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart) III-59

6a. BRAZIL.............. III-60 A.Market Analysis.............. III-60 Current and Future Analysis..............III-60 Despite Challenges, Brazilian Regenerative Medicine Sector Holds Promise.............. III-60 A Major Organ Transplant Market III-60 B.Market Analytics..............III-61 Table 62: Brazilian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)..............III-61

6b. REST OF LATIN-AMERICA..............III-62 A.Market Analysis.............. III-62 Current and Future Analysis..............III-62 B.Market Analytics..............III-62 Table 63: Rest of Latin-America Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) III-62

7. REST OF WORLD.............. III-63 A.Market Analysis.............. III-63 Current and Future Analysis..............III-63 Israel Stem Cell Research in Full Swing III-63 Kuwait - A Rapidly Emerging 'Third World' Country in Organ Transplants.............. III-64 Strategic Corporate Development III-64 Core Dynamics, Ltd. - A Key Israeli Player III-64 B.Market Analytics..............III-65 Table 64: Rest of World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) III-65

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 82

The United States (50) Canada (1) Japan (1) Europe (24) - France (2) - Germany (7) - The United Kingdom (7) - Italy (1) - Rest of Europe (7) Asia-Pacific (Excluding Japan) (4) Middle East (2)
Read the full report: http://www.reportlinker.com/p03549684-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com